Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2026-03-13 00:00:00 ET · period of report 2026-03-12 · accession 0001193125-26-106701 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-13 | 2026-03-12 | SRPT | Mayo Stephen | Dir | S - Sale | $17.02 | -7,239 | 1,765 | -80% | -$123.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-12 | S | D | 7,239 | $17.02 | 1,765 | D | — | — | (F1) Represents a sale of shares of common stock to generate cash for the payment of taxes due as a result of the vesting of certain restricted stock unit awards. |